Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.465 USD | -3.81% |
|
+1.72% | +1.48% |
Jun. 13 | Voyager Therapeutics Names Nathan Jorgensen as Finance Chief | MT |
Jun. 13 | Voyager Therapeutics, Inc. Appoints Nathan Jorgensen as Chief Financial Officer, Effective July 8, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.48% | 479M | |
+40.92% | 55.66B | |
-8.27% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.79% | 26.29B | |
-16.25% | 20.25B | |
+31.20% | 12.76B | |
+28.26% | 12.18B | |
-1.60% | 12.12B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics Appoints Alfred Sandrock as CEO